Download Slide ()

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Protein adsorption wikipedia , lookup

Molecular neuroscience wikipedia , lookup

Thylakoid wikipedia , lookup

SNARE (protein) wikipedia , lookup

Secreted frizzled-related protein 1 wikipedia , lookup

NMDA receptor wikipedia , lookup

Cell membrane wikipedia , lookup

Cell-penetrating peptide wikipedia , lookup

Index of biochemistry articles wikipedia , lookup

Lipid raft wikipedia , lookup

Endomembrane system wikipedia , lookup

Clinical neurochemistry wikipedia , lookup

List of types of proteins wikipedia , lookup

Mitogen-activated protein kinase wikipedia , lookup

Lipid signaling wikipedia , lookup

Western blot wikipedia , lookup

Ultrasensitivity wikipedia , lookup

G protein–coupled receptor wikipedia , lookup

Transcript
Pathways of insulin signaling. The binding of insulin to its plasma membrane receptor activates a cascade of downstream signaling events. Insulin binding
activates the intrinsic tyrosine kinase activity of the receptor dimer, resulting in the tyrosine phosphorylation (Y-P) of the receptor's β subunits and a small
number of specific substrates (yellow shapes): the Insulin Receptor Substrate (IRS) proteins, Gab-1 and SHC; within the membrane, a caveolar pool of
insulin receptor phosphorylates caveolin (Cav), APS, and Cbl. These tyrosine-phosphorylated proteins interact with signaling cascades via SH2 and SH3
domains to mediate the effects of insulin, with specific effects resulting from each pathway. In target tissues such as skeletal muscle and adipocytes, a key
event is the translocation of the Glut4 glucose transporter from intracellular vesicles to the plasma membrane; this translocation is stimulated by both the
Source: Endocrine Pancreas and Pharmacotherapy of Diabetes Mellitus and Hypoglycemia, Goodman & Gilman's: The Pharmacological Basis
caveolar and non-caveolar pathways. In the non-caveolar pathway, the activation of PI3K is crucial, and PKB/Akt (anchored at the membrane by PIP3)
of Therapeutics, 12e
and/or an atypical form of PKC is involved. In the caveolar pathway, caveolar protein flotillin localizes the signaling complex to the caveola; the signaling
Citation:
Brunton
LL,domain
Chabnerinteractions
BA, Knollmann
BC. the
Goodman
Gilman's:
Thethe
Pharmacological
Basis exchange
of Therapeutics,
2011
at:
pathway involves
series
of SH2
that add
adaptor& protein
CrkII,
guanine nucleotide
protein12e;
C3G,
andAvailable
small GTPhttp://mhmedical.com/
Accessed:
August
01,
2017
binding protein, TC10. The pathways are inactivated by specific phosphoprotein phosphatases (eg, PTB1B). In addition to the actions shown, insulin also
Copyright
2017 McGraw-Hill
Education.
rights reserved
stimulates the
plasma ©membrane
Na+,K+-ATPase
by All
a mechanism
that is still being elucidated; the result is an increase in pump activity and a net